Indication
Metastatic pancreatic cancer
1 clinical trial
3 products
1 drug
Clinical trial
A Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Surufatinib in Combination With KN046 and AG Regimen Chemotherapy for the First-Line Treatment of Unresectable Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2024-06-01
Drug
surufatinibProduct
KN046Product
gemcitabineProduct
Nab paclitaxel